Literature DB >> 15134604

Treatment of acute gouty arthritis: one physician's approach and where this management stands relative to developments in the field.

Robert L Wortmann1.   

Abstract

An attack of acute gouty arthritis is one the most painful episodes that can be experienced by humans. Fortunately, there are three classes of agents that can effectively terminate the acute attack. These include colchicine, nonsteroidal anti-inflammatory drugs, and glucocorticoids. If therapy with any one of these is initiated promptly after the onset of symptoms, relief should occur quickly. Recent observations have increased the knowledge of crystal-induced acute inflammatory responses. These observations allow a better understanding of the mechanisms of action of these agents and provide the rationale for using them in combination in severe or refractory cases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134604     DOI: 10.1007/s11926-004-0074-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  22 in total

Review 1.  Renal transplant-associated hyperuricemia and gout.

Authors:  David M Clive
Journal:  J Am Soc Nephrol       Date:  2000-05       Impact factor: 10.121

Review 2.  Effective management of gout: an analogy.

Authors:  R L Wortmann
Journal:  Am J Med       Date:  1998-12       Impact factor: 4.965

Review 3.  Current aspects of colchicine therapy -- classical indications and new therapeutic uses.

Authors:  U Lange; C Schumann; K L Schmidt
Journal:  Eur J Med Res       Date:  2001-04-20       Impact factor: 2.175

4.  Gout presenting as infectious arthritis. Two case reports.

Authors:  R A Rogachefsky; R Carneiro; R D Altman; W E Burkhalter
Journal:  J Bone Joint Surg Am       Date:  1994-02       Impact factor: 5.284

5.  Diagnostic value of the colchicine therapeutic trial.

Authors:  S I Wallace; D Bernstein; H Diamond
Journal:  JAMA       Date:  1967-02-20       Impact factor: 56.272

6.  Local ice therapy during bouts of acute gouty arthritis.

Authors:  Naomi Schlesinger; Michelle A Detry; Bart K Holland; Daniel G Baker; Anna M Beutler; Marina Rull; Bruce I Hoffman; H Ralph Schumacher
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

7.  The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis.

Authors:  Wako Urano; Hisashi Yamanaka; Hiroshi Tsutani; Hiroshi Nakajima; Yuko Matsuda; Atsuo Taniguchi; Masako Hara; Naoyuki Kamatani
Journal:  J Rheumatol       Date:  2002-09       Impact factor: 4.666

Review 8.  S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity.

Authors:  Wolfgang Nacken; Johannes Roth; Clemens Sorg; Claus Kerkhoff
Journal:  Microsc Res Tech       Date:  2003-04-15       Impact factor: 2.769

9.  Concomitant septic and gouty arthritis--an analysis of 30 cases.

Authors:  K H Yu; S F Luo; L B Liou; Y-J J Wu; W P Tsai; J Y Chen; H H Ho
Journal:  Rheumatology (Oxford)       Date:  2003-04-16       Impact factor: 7.580

10.  Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis.

Authors:  Carle Ryckman; Shaun R McColl; Karen Vandal; Rinaldo de Médicis; André Lussier; Patrice E Poubelle; Philippe A Tessier
Journal:  Arthritis Rheum       Date:  2003-08
View more
  1 in total

Review 1.  Management of gout in older adults: barriers to optimal control.

Authors:  Karl T Hoskison; Robert L Wortmann
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.